Literature DB >> 20846522

The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.

Chia-Hung Chiang1, Chin-Chou Huang, Wan-Leong Chan, Jaw-Wen Chen, Hsin-Bang Leu.   

Abstract

OBJECTIVES: We aimed to investigate the correlation between non-alcoholic fatty liver disease (NAFLD) and risk of cardiovascular disease (CVD). DESIGN AND METHODS: We analyzed 724 subjects without CVD according to presence or absence of NAFLD. Logistic regression model was used to determine if NAFLD was an independent risk factor of CVD.
RESULTS: Subjects with NAFLD had increased percentage of 10-year cardiovascular risk ≧10% compared to those without NAFLD (p<0.001). The severity of NAFLD significantly correlated with increasing Framingham risk score and C-relative protein (CRP) value. After adjusting for conventional CVD risk factors, the presence of NAFLD was an independent predictor for future CVD risk ≧10% [odds ratio: 1.89, p=0.004]. Subgroup analysis showed the predictive value of NAFLD was significant among aged subjects and those with increased baseline hsCRP level.
CONCLUSIONS: NAFLD is independently associated with increased CVD risk, especially among elderly subjects and those with increased CRP level.
Copyright © 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846522     DOI: 10.1016/j.clinbiochem.2010.09.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

1.  High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.

Authors:  Stefan B Puchner; Michael T Lu; Thomas Mayrhofer; Ting Liu; Amit Pursnani; Brian B Ghoshhajra; Quynh A Truong; Stephen D Wiviott; Jerome L Fleg; Udo Hoffmann; Maros Ferencik
Journal:  Radiology       Date:  2014-11-04       Impact factor: 11.105

2.  Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study.

Authors:  Nadia Pallotta; Tiziana Filardi; Anna Carnovale; Luciano Nieddu; Paola Mariani; Giuseppina Vincoli; Andrea Lenzi; Susanna Morano
Journal:  Endocrine       Date:  2016-07-15       Impact factor: 3.633

3.  Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis.

Authors:  Lavanya Ravichandran; Shaun G Goodman; Andrew T Yan; Aurora Mendelsohn; Joel G Ray
Journal:  Heart Asia       Date:  2012-10-12

4.  Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance?

Authors:  Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2017-07-04

5.  Moderate oxidative stress and high antioxidative activity are associated with steatosis in Japanese males.

Authors:  Takuya Imatoh; Seiichirou Kamimura; Shinichi Tanihara
Journal:  Clin Transl Sci       Date:  2012-12-06       Impact factor: 4.689

Review 6.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

7.  Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

Authors:  Giovanni Tarantino; Carmine Finelli; Annamaria Colao; Domenico Capone; Marianna Tarantino; Ernesto Grimaldi; Donato Chianese; Saverio Gioia; Fabrizio Pasanisi; Franco Contaldo; Francesco Scopacasa; Silvia Savastano
Journal:  J Transl Med       Date:  2012-03-16       Impact factor: 5.531

8.  A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.

Authors:  Natalia Lampon; J Carlos Tutor
Journal:  Ups J Med Sci       Date:  2010-12-29       Impact factor: 2.384

9.  Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.

Authors:  Chia-Hung Chiang; Po-Hsun Huang; Fa-Po Chung; Zu-Yin Chen; Hsin-Bang Leu; Chin-Chou Huang; Tao-Cheng Wu; Jaw-Wen Chen; Shing-Jong Lin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 10.  Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.

Authors:  Martine C Morrison; Robert Kleemann
Journal:  Front Immunol       Date:  2015-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.